Physician

John Kennison Hudson, M.D.

According to 2025 Medicare claims, John Hudson, M.D. (NPI: 1700863438) practices hematology/oncology in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Columbia, GA. This provider's primary affiliated billing organization is AUGUSTA ONCOLOGY ASSOCIATES PC (NPI: 1912917824; TIN: 581481590) and primary practice location at 30909-6520.

Hudson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 758 traditional Medicare patients, billed 150,507 HCPCS/CPT codes, and received $1,951,824 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,112 prescription claims across 237 beneficiaries totaling $1,944,009 in drug costs, led by Venclexta (Venetoclax). DME data shows 26 claims. Open Payments data shows 14 records totaling $374. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $952,844 and ending at $1,944,009. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	793	171,481	$2,010,648
2016	729	179,307	$1,884,041
2017	725	144,585	$1,520,008
2018	859	221,769	$2,507,081
2019	1,030	255,034	$3,071,279
2020	1,017	269,419	$3,217,146
2021	946	293,016	$3,171,561
2022	715	128,940	$1,561,853
2023	723	151,437	$1,835,355
2024	758	150,507	$1,951,824

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	169	1,313	$952,844
2016	161	1,330	$1,542,353
2017	167	1,237	$2,007,247
2018	235	1,389	$2,180,958
2019	247	1,402	$2,102,553
2020	219	1,378	$2,018,252
2021	246	1,505	$2,049,510
2022	239	1,229	$2,137,164
2023	232	957	$1,363,284
2024	237	1,112	$1,944,009

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	24	$944
2016	N/R	N/R	N/R
2017	N/R	35	$1,015
2018	N/R	73	$6,680
2019	N/R	11	$2,721
2020	N/R	25	$2,235
2021	N/R	N/R	N/R
2022	N/R	35	$1,305
2023	N/R	28	$3,840
2024	N/R	26	$540

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	334	735	$86
82728	Ferritin (blood protein) level	182	379	$13
80053	Blood test, comprehensive group of blood chemicals	505	1,204	$10
36415	Insertion of needle into vein for collection of blood sample	547	1,356	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	530	1,320	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Venclexta	Venetoclax	54	1,604	$497,028
Ojjaara	Momelotinib Dihydrochloride	13	390	$341,361
Brukinsa	Zanubrutinib	13	390	$194,474
Imbruvica	Ibrutinib	11	320	$186,147
Xtandi	Enzalutamide	12	360	$152,108

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	14	$365
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	12	$175

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$374	Siemens Medical Solutions USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John Kennison Hudson, M.D.?

Tedicare shows public-source Medicare data for John Kennison Hudson, M.D. (NPI 1700863438), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John Kennison Hudson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John Kennison Hudson, M.D.?

John Kennison Hudson, M.D. is linked to AUGUSTA ONCOLOGY ASSOCIATES PC (billing NPI 1912917824) in the available physician profile data.

Does John Kennison Hudson, M.D. have Open Payments data?

John Kennison Hudson, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.